Mfn Partners Management, LP Aclaris Therapeutics, Inc. Transaction History

Mfn Partners Management, LP

  • $3.52 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$1.5 - $2.71 $5.01 Million - $9.05 Million
-3,338,718 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$1.04 - $1.73 $687,733 - $1.14 Million
-661,282 Reduced 16.53%
3,338,718 $5.41 Million
Q4 2019

Feb 13, 2020
BUY
$1.02 - $1.97 $2.55 Million - $4.93 Million
2,500,000 Added 166.67%
4,000,000 $7.56 Million
Q4 2018

Feb 14, 2019
BUY
$6.3 - $15.4 $9.45 Million - $23.1 Million
1,500,000 New
1,500,000 $11.1 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $165M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Mfn Partners Management, LP Portfolio

Follow Mfn Partners Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mfn Partners Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mfn Partners Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email